US Stock MarketDetailed Quotes

TCRX TScan Therapeutics

Watchlist
  • 4.260
  • +0.320+8.12%
Close Nov 22 16:00 ET
  • 4.260
  • 0.0000.00%
Post 16:00 ET
227.36MMarket Cap-4484P/E (TTM)

TScan Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TScan Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.381M--
--2024/Q4-- / 1.510M--
--2024/Q31.049M / 1.173M--
--2024/Q2536.000K / 1.819M--
--2024/Q1566.000K / 4.300M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.381M--
--2024/Q4-- / 1.510M--
--2024/Q31.049M / 1.173M--
--2024/Q2536.000K / 1.819M--
--2024/Q1566.000K / 4.300M--

Unlock Free Earnings Estimates

TScan Therapeutics Earnings Reports

  • TScan Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 12 12:26 ET

  • TScan Therapeutics | 8-K: TScan Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

    Nov 12 12:26 ET

  • TScan Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 12 07:35 ET

  • TScan Therapeutics | 8-K: TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

    Aug 12 07:20 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 15, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data